# Efficacy and Safety of Intravitreal Triamcinolone Acetonide in Eyes With Post Vitrectomy Diabetic Vitreous Hemorrhage

> **NCT00300014** · NA · UNKNOWN · sponsor: **Asan Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- Post Vitrectomy State
- Recurrent Diabetic Vitreous Hemorrhage

## Interventions

- **PROCEDURE:** Intravitreal triamcinolone injection
- **PROCEDURE:** Air-fluid exchange

## Key facts

- **NCT ID:** NCT00300014
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-01
- **Primary completion:** —
- **Final completion:** 2007-05
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2007-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00300014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00300014, "Efficacy and Safety of Intravitreal Triamcinolone Acetonide in Eyes With Post Vitrectomy Diabetic Vitreous Hemorrhage". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00300014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
